There are 1105 resources available
Q&A and discussion
Session: Session in collaboration with AACR - The expanding portfolio of targeted and cellular therapies in oncology-mechanisms of action and proofs of principle
Resources:
Webcast
Q&A and discussion
Session: Mini Oral session: Genitourinary tumours
Resources:
Webcast
Q&A and discussion
Session: Focus on treatment of specific sarcoma types
Resources:
Webcast
272MO - PUNCH01: Interim results from a phase II study of intra-arterial chemotherapy (IAC) combined with tislelizumab and Bacillus Calmette-Guerin (BCG) in high-risk non-muscle-invasive bladder cancer (HR NMIBC)
Presenter: Zongren Wang
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
273MO - DURANCE: A phase Ib/II study to assess the safety and activity of durvalumab (MEDI4736) in combination with S-488210/S-488211 vaccine in non-muscle invasive bladder cancer
Presenter: Gianmarco Leone
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
274MO - Efficacy and safety of fruquintinib combined with serplulimab as 1st line treatment in advanced non-clear cell renal cell carcinoma (nccRCC): A single-arm, multicentre clinical trial
Presenter: Jiwei Huang
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 272MO, 273MO and 274MO
Presenter: Johan Chan
Session: Mini Oral session: Genitourinary tumours
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Genitourinary tumours
Resources:
Webcast
275MO - Neoadjuvant sacituzumab govitecan, followed by radical cystectomy, for patients with muscle-invasive bladder cancer (MIBC): Updated interim results of SURE-01 trial
Presenter: Brigida Maiorano
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
338MO - Efficacy and safety of tislelizumab (T) combined with gemcitabine and cisplatin (GC) for patients with localized muscle-invasive bladder cancer (MIBC) after radical local surgery: A prospective, phase II study
Presenter: Ming Cao
Session: Mini Oral session: Genitourinary tumours
Resources:
Abstract